Cumberland Pharmaceuticals Inc. (CPIX)
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous Close | 1.2400 |
| Open | 1.2300 |
| Bid | 0.9216 x 200 |
| Ask | 1.6700 x 200 |
| Day's Range | 1.2300 - 1.3000 |
| 52 Week Range | 1.2000 - 2.3600 |
| Volume | |
| Avg. Volume | 9,203 |
| Market Cap | 17.619M |
| Beta (5Y Monthly) | 0.20 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.7200 |
| Earnings Date | Nov 05, 2024 - Nov 11, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Associated Press Finance
Cumberland: Q2 Earnings Snapshot
CPIX) on Tuesday reported a loss of $1.1 million in its second quarter. On a per-share basis, the Nashville, Tennessee-based company said it had a loss of 8 cents. Earnings, adjusted for non-recurring costs and stock option expense, were 1 cent per share.
PR NewswireCumberland Pharmaceuticals Reports 16% Sequential Revenue Growth in Second Quarter 2024
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced significantly improved financial results and a favorable overall company performance for the second quarter of 2024.
- PR Newswire
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2024 FINANCIAL RESULTS
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its second quarter 2024 financial results and provide a company update after the market closes on Tuesday, Aug. 6, 2024.
© 2024 Yahoo. All rights reserved.